Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 5Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Breast Neoplasms 1

Interventions

Colposcopy 17Methods 14Early Intervention, Educational 12Cisplatin 12Brachytherapy 11Human Papillomavirus DNA Tests 10Blood Specimen Collection 10Educational Status 9Biopsy 8Standard of Care 7Radiotherapy 7Patient Navigation 7Papanicolaou Test 7Magnetic Resonance Spectroscopy 7Vaginal Smears 6Sentinel Lymph Node Biopsy 6Mass Screening 6Counseling 6Acetic Acid 6Watchful Waiting 5Surveys and Questionnaires 5Radiotherapy, Intensity-Modulated 5Therapeutics 4Specimen Handling 4Radiation Dose Hypofractionation 4Practice Guidelines as Topic 4Paclitaxel 4Transurethral Resection of Prostate 3Radiation 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Uterine Cervical Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT04017377 2020-04-28

VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer

Peking University Third Hospital

Phase NA Unknown
15 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡